<DOC>
	<DOCNO>NCT00639080</DOCNO>
	<brief_summary>Purpose : To assess prior need lipid lower therapy patient type 2 diabetes . Background/Hypothesis : At present , lipid lower therapy , usually HMG-CoA reductase inhibitor `` statin '' , recommend therapy select patient type 2 diabetes mellitus ( DM ) . The use statins primary prevention CVD clear . Some primary prevention study find statistically significant benefit others ( CARDS ASPEN ) . Although low-density lipoprotein ( LDL ) traditionally key marker cardiovascular disease risk ( CVD ) risk thus guide statin treatment , recent year apolipoprotein B ( apoB ) emerge independent risk factor CVD . In recent study , Tildesley H. et al . show 500 patient type 2 DM lipid lower therapy discordance LDL apoB value . Specifically , find among patient fail achieve LDL-C target , 13 % men , 24 % woman le 50 13 % woman great 50 meet apoB target . In word , LDL level would indicate treatment , apoB level would . Objectives : The investigator propose measure lipid parameter lipid lower therapy compare lipid parameter one two month discontinuation therapy select patient type 2 DM low risk CVD . Lipid parameter measure include : high-density lipoprotein ( HDL ) - cholesterol , LDL-cholesterol , triglyceride , total cholesterol , total cholesterol : HDL-cholesterol ratio apoB . As well , A1C measure .</brief_summary>
	<brief_title>Necessity Lipid Lowering Therapy Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>LDL &lt; 2.5 mmol/L total cholesterol : HDLcholesterol ratio &lt; 4.0 Blood pressure ≤ 130/80 mmHg No personal family history CVD No history proteinuria renal failure Taking atorvastatin ( lipitor ) dosage ≤ 10 mg , equivalent dosage statin follow requirement ( Simvastatin ≤ 20 mg , pravastatin ≤ 40 mg , rosuvastatin ≤ 5 mg , fluvastatin ≤ 40 mg lovastatin ≤ 40 mg ) Calculated UKPDS Risk Engine low risk ( risk le 15 % ) Coronary Heart Disease ( CHD ) , fatal CHD , stroke fatal stroke ( UKPDS Risk Engine provide risk estimate individual type 2 diabetes know heart disease ( 1 ) , calculate patient 's risk involve consider risk factor age , sex , incidence smoking lipid level ) Patients meet criterion willing participate include study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Dyslipidemia</keyword>
</DOC>